China National Medicines Corporation Ltd. (SHA:600511)
26.10
+0.30 (1.16%)
Sep 30, 2026, 3:00 PM CST
SHA:600511 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:600511 stock has a consensus rating of "Strong Buy" and an average price target of ¥36.43. The average 1-year stock price forecast is 39.58% higher than the current stock price, while the lowest is ¥34.86 (+33.56%) and the highest is ¥38.00 (+45.59%).
Price Target: ¥36.43 (+39.58%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:600511 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Mar '26 | Apr '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Financial Forecast
Revenue This Year
55.20B
from 52.47B
Increased by 5.21%
Revenue Next Year
57.99B
from 55.20B
Increased by 5.06%
EPS This Year
2.88
from 2.61
Increased by 10.27%
EPS Next Year
2.82
from 2.88
Decreased by -2.08%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.